Oregovomab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | CA125 |
Clinical data | |
Trade names | OvaRex |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Molar mass | ca. 150 kg/mol |
(what is this?) |
Oregovomab (marketed under the trade name OvaRex) is a mouse monoclonal antibody it binds to the antigen CA125, a carbohydrate antigen. It is designed for the treatment of ovarian cancer.[1]
This drug was developed by Corp.
Adverse drug effects[]
This section is empty. You can help by . (October 2014) |
References[]
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Oregovomab, American Medical Association.
Categories:
- Drugs not assigned an ATC code
- Monoclonal antibodies for tumors
- Experimental cancer drugs
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs